Ajanta Pharma has informed that the meeting of the Board of Directors of the Company is scheduled on 31/10/2023 to consider and approve Unaudited Consolidated and Standalone Financial Results for the second quarter and half year ended 30.09.2023.
The above information is a part of company’s filings submitted to BSE.